H.I.G. Capital, a global private equity investment firm, has acquired WillowWood, a manufacturer of prosthetic products, for an undisclosed amount. This transaction represents a corporate acquisition, signifying a change in ownership for WillowWood as it becomes part of H.I.G. Capital’s portfolio.
WillowWood is dedicated to making daily activities achievable for amputees. The company strives to deliver comfort, durability, and independence through every prosthetic product it manufactures and service it provides. This mission has been a long-standing tradition and a core focus for WillowWood in the specialized medical device sector.
The acquisition by H.I.G. Capital is a strategic move aimed at supporting WillowWood’s continued growth and market expansion. As a private equity firm, H.I.G. Capital typically partners with management teams to provide capital and operational expertise, enabling portfolio companies to enhance their capabilities and reach. This investment is expected to bolster WillowWood’s capacity for innovation and product development within the prosthetic industry.
Expected synergies from this acquisition include leveraging H.I.G. Capital’s resources to accelerate WillowWood’s research and development efforts, expand its distribution channels, and strengthen its overall market position. The combined entity is poised to further WillowWood’s mission of improving the quality of life for amputees worldwide by continuing to deliver advanced prosthetic solutions.